The role of SOCs in abnormal Ca2+ handling in DMD has been investigated, and targeting of SOCs to restore Ca2+ homeostasis for DMD therapies has been discussed previously [18,54]. The gene discussed is CISH; the disease is Duchenne muscular dystrophy.